To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells.
With an amount totalling 14 million Swiss francs, the Eckenstein-Geigy Foundation is sponsoring a new professorship in Epidemiology and Household Economics. The professorship at the University of Basel will be based at the Swiss Tropical and Public Health Institute (Swiss TPH).
The BK polyomavirus often causes complications after kidney transplantation. A research group from the Department of Biomedicine at the University and the University Hospital of Basel has now been able to show, that the immunosuppressive drug Tacrolimus directly activates the replication of the virus and could thus be responsible for these complications.
The startup company “T3 Pharmaceuticals” at the Biozentrum of the University of Basel has developed a fast and simple tool to selectively inject diverse proteins into cells.
Scientists from the Swiss Nanoscience Institute and the Department of Physics at the University of Basel have demonstrated for the first time how electrons are transported from a superconductor through a quantum dot into a metal with normal conductivity.
The next edition of “Uni-Ein-Blicke” on November 24 will visit the Swiss Tropical and Public Health Institute.
Exercise is healthy – this applies to all of us, especially though for people suffering from type 2 diabetes. Researchers from the University of Basel were able to show that fitness games, or “exergames”, for the Nintendo Wii console are suitable to increase cardiorespiratory fitness in type 2 diabetic patients and thus lower the risk of related heart disease.
Microwave field imaging is becoming increasingly important, as microwaves play an essential role in modern communications technology and can also be used in medical diagnostics. Researchers from the Swiss Nanoscience Institute and the Department of Physics at the University of Basel have now independently developed two new methods for imaging microwave fields.
The South African Ann Grobler, Director of the Preclinical Drug Development Platform South Africa and professor for Pharmacology at North-West University, is already leading her second joint research program with scientists from Switzerland and South Africa.
